Retatrutide
This product is in research for the following:
Retatrutide is an investigational once-weekly injectable medication. It is designed as a "triple agonist" that simultaneously targets three different metabolic hormones: GLP-1, GIP, and glucagon.
How It Works
GLP-1 & GIP: Slows digestion to keep food in the stomach longer and signals the brain's satiety centers to reduce appetite and cravings.
Glucagon: Stimulates the breakdown of fat cells and enhances the body's energy expenditure.
Efficacy and Trial Results
Clinical trials for retatrutide have shown record-setting potential for weight loss and glycemic control.
Weight Loss: In Phase 2 trials, adults taking the highest dose (12 mg) for 48 weeks lost an average of 24.2% of their body weight, outperforming current medications on the market.
Type 2 Diabetes: Trials demonstrated significant drops in HbA1c levels, with 35% to 40% of participants achieving normal blood sugar levels.
All products exceed 99% purity from our sourced vendor's. All Products are for Research Only and Not For Human Consumption. Products are tested in the US by Freedom Diagnostics a USA based company.